top of page

53rd COS Programme

Old Divinity School, St John’s College, Cambridge, UK

4-5th September 2025

18 CPD self accredited points

Topic: Embrogenesis and the Eye 

Chairs: Mr Manoj Parulekar, Oxford and Birmingham, UK & Prof Tony Moore, London, UK

Academic Organiser: Mr Martin Snead, Cambridge, UK

 

Registration opens: 08:00 Thursday and Friday.

2025 COS logo.png
Friday

Thursday 4th September 2025

Time
Topic
Speaker
Location
Time
Topic
Speaker
08:45
Welcome
Martin Snead
Cambridge, UK
09:00
Normal embryogenesis of the human eye
Robert Johnston
Baltimore, USA
09:30
Ocular embryogenesis in non-primates
David Williams
Cambridge, UK
10:00
Understanding the molecular pathways for dysgenesis of the eye
Mariya Moosajee
London, UK
10:30
Coffee
11:00
Molecular genetic regulation of retinal development
Thomas A. Reh
Seattle, USA
11:30
The growth of the eye and refractive error
Chris Hammond
London, UK
12:00
Embryodysgenesis of the lid and orbit
London, UK
12:30
Lunch
14:00
Developmental disorders of the cornea
Susmito Biswas
Manchester, UK
14:30
Therapeutic manipulation of limbal embryology
Newcastle, UK
15:00
Pathobiology of the developing lens
Frank J. Lovicu
Sydney, Australia
15:30
16:00
Ocular development and glaucoma – therapeutic implications
Peng Khaw
London, UK
16:30
Developmental abnormalities of the uveal tract
Manoj Parulekar
Birmingham & Oxford, UK
17:00

Friday 5th September 2025

Time
Topic
Speaker
Location
09:00
Prenatal molecular genetic diagnosis of ocular dysgenesis
Manchester, UK
09:30
Congenital abnormalities of the optic nerve
Rochester, USA
10:00
Retinal detachment complicating coloboma
Martin Snead
Cambridge, UK
10:30
COFFEE
11:00
Embryonic development of the human macula
Marcus Fruttiger
London, UK
11:30
Abnormalities of retinal vascular embryogenesis
Tony Moore
London, UK
12:00
The premature eye and management strategies for ROP
Utah, USA
12:30
LUNCH
14:00
Vitreous dysgenesis in the embryonic eye
Thomas Nixon
Cambridge, UK
14:30
Persistent Foetal Vasculature: pathogenesis and management
Rob Henderson
London, UK
15:00
TEA
15:30
Gene therapy for ocular disease: opportunities and obstacles
Iowa, USA
16:00
Manipulating stem cells for retinal disease
Maddison, USA
16:30
Oncogenesis and the embryonic eye
Philadelphia, USA
17:00
CLOSE
Thursday
bottom of page